FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120219953> ?p ?o ?g. }

• W3120219953 endingPage "799" @default.
• W3120219953 startingPage "794" @default.
• W3120219953 abstract "Ifosfamide, an alkylating agent, is widely used in the treatment of malignant diseases. However, these treatments are often limited due to the incidence of neuropsychiatric symptoms such as delirium, seizures, hallucinations and agitation. In this study, we examined risk factors for neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapy.The study cases were patients with cancer receiving ifosfamide-based chemotherapy between April 2007 and March 2018. Risk analysis for ifosfamide-related neuropsychiatric symptoms was determined by time-dependent Cox proportional hazard regression analysis.Of 183 eligible patients, 32 patients (17.5%) experienced ifosfamide-related neuropsychiatric symptoms. Time-dependent Cox proportional hazard model showed that the albumin-bilirubin (ALBI) score was significantly correlated with the incidence of ifosfamide-related neuropsychiatric symptoms (hazard ratio [HR] =1.45, 95% confidence interval [CI] = 1.05-2.01, p = 0.025). Additionally, there were correlations between the predicted risk of neuropsychiatric symptoms and ifosfamide-dose per cycle (HR =0.51, 95% CI = 0.27-0.94, p = 0.030) and creatinine clearance (Ccr) (HR = 0.53, 95% CI = 0.28-1.00, p = 0.050). In contrast, neither serum albumin nor total bilirubin was a significant risk factor for neuropsychiatric symptoms.These findings indicate that ALBI score may be a useful biomarker for predicting neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapy." @default.
• W3120219953 created "2021-01-18" @default.
• W3120219953 creator A5000308443 @default.
• W3120219953 creator A5001015536 @default.
• W3120219953 creator A5002271734 @default.
• W3120219953 creator A5021462550 @default.
• W3120219953 creator A5029164270 @default.
• W3120219953 creator A5030207435 @default.
• W3120219953 creator A5032420218 @default.
• W3120219953 creator A5051746428 @default.
• W3120219953 creator A5055783995 @default.
• W3120219953 creator A5055962201 @default.
• W3120219953 creator A5062786061 @default.
• W3120219953 creator A5063044564 @default.
• W3120219953 creator A5065200598 @default.
• W3120219953 creator A5065534862 @default.
• W3120219953 creator A5076715179 @default.
• W3120219953 creator A5086245366 @default.
• W3120219953 date "2021-01-04" @default.
• W3120219953 modified "2023-09-25" @default.
• W3120219953 title "Albumin‐bilirubin score for predicting neuropsychiatric symptoms in patients receiving ifosfamide‐based chemotherapy" @default.
• W3120219953 cites W1154364364 @default.
• W3120219953 cites W1550111394 @default.
• W3120219953 cites W159104142 @default.
• W3120219953 cites W2000607921 @default.
• W3120219953 cites W2038017526 @default.
• W3120219953 cites W2046563782 @default.
• W3120219953 cites W2064113214 @default.
• W3120219953 cites W2078534295 @default.
• W3120219953 cites W2091926106 @default.
• W3120219953 cites W2096988642 @default.
• W3120219953 cites W2119190881 @default.
• W3120219953 cites W2144579228 @default.
• W3120219953 cites W2151863911 @default.
• W3120219953 cites W2510441948 @default.
• W3120219953 cites W2783402787 @default.
• W3120219953 cites W2972924006 @default.
• W3120219953 cites W2979611698 @default.
• W3120219953 cites W4232461964 @default.
• W3120219953 cites W4246005806 @default.
• W3120219953 doi "https://doi.org/10.1111/jcpt.13355" @default.
• W3120219953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33393716" @default.
• W3120219953 hasPublicationYear "2021" @default.
• W3120219953 type Work @default.
• W3120219953 sameAs 3120219953 @default.
• W3120219953 citedByCount "1" @default.
• W3120219953 countsByYear W31202199532022 @default.
• W3120219953 crossrefType "journal-article" @default.
• W3120219953 hasAuthorship W3120219953A5000308443 @default.
• W3120219953 hasAuthorship W3120219953A5001015536 @default.
• W3120219953 hasAuthorship W3120219953A5002271734 @default.
• W3120219953 hasAuthorship W3120219953A5021462550 @default.
• W3120219953 hasAuthorship W3120219953A5029164270 @default.
• W3120219953 hasAuthorship W3120219953A5030207435 @default.
• W3120219953 hasAuthorship W3120219953A5032420218 @default.
• W3120219953 hasAuthorship W3120219953A5051746428 @default.
• W3120219953 hasAuthorship W3120219953A5055783995 @default.
• W3120219953 hasAuthorship W3120219953A5055962201 @default.
• W3120219953 hasAuthorship W3120219953A5062786061 @default.
• W3120219953 hasAuthorship W3120219953A5063044564 @default.
• W3120219953 hasAuthorship W3120219953A5065200598 @default.
• W3120219953 hasAuthorship W3120219953A5065534862 @default.
• W3120219953 hasAuthorship W3120219953A5076715179 @default.
• W3120219953 hasAuthorship W3120219953A5086245366 @default.
• W3120219953 hasBestOaLocation W31202199531 @default.
• W3120219953 hasConcept C118552586 @default.
• W3120219953 hasConcept C120665830 @default.
• W3120219953 hasConcept C121332964 @default.
• W3120219953 hasConcept C126322002 @default.
• W3120219953 hasConcept C141071460 @default.
• W3120219953 hasConcept C143998085 @default.
• W3120219953 hasConcept C207103383 @default.
• W3120219953 hasConcept C2776694085 @default.
• W3120219953 hasConcept C2777506904 @default.
• W3120219953 hasConcept C2778119113 @default.
• W3120219953 hasConcept C2779753318 @default.
• W3120219953 hasConcept C44249647 @default.
• W3120219953 hasConcept C50382708 @default.
• W3120219953 hasConcept C61511704 @default.
• W3120219953 hasConcept C71924100 @default.
• W3120219953 hasConcept C90924648 @default.
• W3120219953 hasConceptScore W3120219953C118552586 @default.
• W3120219953 hasConceptScore W3120219953C120665830 @default.
• W3120219953 hasConceptScore W3120219953C121332964 @default.
• W3120219953 hasConceptScore W3120219953C126322002 @default.
• W3120219953 hasConceptScore W3120219953C141071460 @default.
• W3120219953 hasConceptScore W3120219953C143998085 @default.
• W3120219953 hasConceptScore W3120219953C207103383 @default.
• W3120219953 hasConceptScore W3120219953C2776694085 @default.
• W3120219953 hasConceptScore W3120219953C2777506904 @default.
• W3120219953 hasConceptScore W3120219953C2778119113 @default.
• W3120219953 hasConceptScore W3120219953C2779753318 @default.
• W3120219953 hasConceptScore W3120219953C44249647 @default.
• W3120219953 hasConceptScore W3120219953C50382708 @default.
• W3120219953 hasConceptScore W3120219953C61511704 @default.
• W3120219953 hasConceptScore W3120219953C71924100 @default.
• W3120219953 hasConceptScore W3120219953C90924648 @default.
• W3120219953 hasIssue "3" @default.

• next